Why the study?
Diagnosis of aortic dissection mainly relies on imaging, while reliable biomarkers to detect or monitor the condition remain under investigation.
What is the diagnostic and prognostic value of biomarkers in aortic dissection?
What is the diagnostic and prognostic value of biomarkers in aortic dissection?
Biomarkers such as proteins, RNAs, and DNAs hold potential for improving the early detection, rapid diagnosis, and personalized management of aortic dissection.
Identified biomarker candidates in aortic dissection may aid detection; leaves open prospective validation before any clinical role.
Aortic dissection is a life-threatening condition for which diagnosis mainly relies on imaging examinations, while reliable biomarkers to detect or monitor are still under investigation. Recent advances in technologies provide an unprecedented opportunity to yield the identification of clinically valuable biomarkers, including proteins, ribonucleic acids (RNAs), and deoxyribonucleic acids (DNAs), for early detection of pathological changes in susceptible patients, rapid diagnosis at the bedside after onset, and a superior therapeutic regimen primarily within the concept of personalized and tailored endovascular therapy for aortic dissection.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: